Kelly Vana's Nursing Leadership and Management. Группа авторов

Чтение книги онлайн.

Читать онлайн книгу Kelly Vana's Nursing Leadership and Management - Группа авторов страница 62

Kelly Vana's Nursing Leadership and Management - Группа авторов

Скачать книгу

Increased accountability for performance Consensus documents or guidelines that recommend decreases in utilization Consensus documents or guidelines that recommend increases in utilization Technological advances in the biological and clinical sciences Better understanding of the risk factors of diseases and prevention initiatives (e.g., smoking‐prevention programs, cholesterol‐lowering drugs) New procedures and technologies (e.g., hip replacement, stent insertion, magnetic resonance imaging (MRI)) New drugs, expanded use of existing drugs Increased supply of services (e.g., ambulatory surgery centers, assisted living residences) Increase in chronic illness Aging of the population Discovery and implementation of treatments that cure or eliminate diseases Public health and sanitation advances (e.g., quality standards for food and water distribution) Growing elderly population:more functional limitations associated with agingmore illness associated with agingmore deaths among the increased number of elderly (the elderly are correlated with high utilization of services) Increased ethnic and cultural diversity of the population Lack of insurance coverage Low income Growth in national population Efforts to eliminate disparities in access and outcomes Changes in the supply and education of health professionals Decreased supply (e.g., hospital closures, large numbers of nursing and medical practitioners and nurses retiring) Shifts to other sites of care may cause declines in utilization of staff at the original sites:as technology allows shifts (e.g., ambulatory surgery)as alternative sites of care become available (e.g., assisted living) Increase in chronic conditions Growth in national population Social morbidity (e.g., increased AIDS, drugs, violence, disasters) Disparities in access to health services and outcomes New health problems (e.g., HIV/AIDS, bioterrorism, earthquakes) Access to patient information Changes in consumer preferences (e.g., home birthing, more self‐care, alternative medicine) Changes in consumer demand Globalization and expansion of the world economy Growth in uninsured population Growth in national population Cost control and competition for limited resources Insurance payer pressures to reduce costs Increased health insurance coverage Consumer and employee pressures for more comprehensive insurance coverage Changes in consumer preferences and demand (e.g., cosmetic surgery, hip and knee replacements, direct marketing of pharmaceuticals)

      Source: Adapted from Bernstein, A. B., Hing, E., Moss, A. J., Allen, K. F., Siller, A. B., Tiggle, R. B. (2003). Health care in America: Trends in utilization. Hyattsville, MD: National Center for Health Statistics; and Shortell, S. M., & Kaluzny, A. D. (2006). Health care management (5th ed.). Clifton Park, NY: Delmar Cengage Learning. And CDC. (2018). National Center for Health Statistics. Health, United States, 2017: With special feature on mortality.. National Center for Health Statistics. Health, United States, 2017: With special feature on mortality. Retrieved from www.cdc.gov/nchs/data/hus/hus17.pdf

      Cost Containment Strategies

      Research has suggested the hazards and ethical problems in the overuse of services in fee‐for‐service settings (where payment is made based on service rendered to individuals for individual services) rather than service underuse in capitated care (where payment is made based on service rendered to a group of patients) (Berwick 1994; Leape et al., 1990). Over the years, cost containment strategies have targeted the financing and reimbursement sides of health care. Financing strategies have used health services regulation and limitation by means of taxes or insurance premiums and encouraged competition such as managed competition. Reimbursement containment strategies have used regulatory and competitive price controls and utilization controls, such as capitation, patient cost sharing, and utilization management. Capitation and prospective payment have had some of the most significant impacts on cost containment.

      Capitation

      Even though legislation creating managed care was passed in 1973 (the Health Maintenance Organization Act), managed care did not become a major player or driving force in health care until the late 1980s. In an effort to reduce the number of hospitalizations and control profit incentives for health care providers, managed care plans offered hospitals and practitioners a capitated set fee for office visits and hospitalizations for a group of patients. Capitation is the payment of a fixed dollar amount, per person, for the provision of health services to a patient population for a specified period of time, for example, 1 year. Under capitation, health care organizations benefit from using their financial resources to keep people well. Otherwise, health care providers bear the financial loss. Then in the mid‐1990s, the U.S. population had quality concerns with this system and backlashed against managed care organizations.

      Prospective Payment

      Reacting to rapidly increasing costs to Medicare, the Tax Equity and Fiscal Responsibility Act (TEFRA) passed in 1982 mandated the Prospective Payment System (PPS) to control health care costs. For Medicare Part A services, PPS uses Medicare's administrative data to develop and continually refine PPS payments based on diagnosis‐related groups (DRGs), that is, patients with similar diagnoses. The PPS is a method of reimbursement in which Medicare payment is made based on a predetermined, fixed amount for reimbursement to acute inpatient hospitals, home health agencies, hospices, hospital outpatient and inpatient psychiatric facilities, inpatient rehabilitation facilities, long‐term care hospitals, and skilled nursing facilities. For Medicare Part B services, the Resource‐Based Relative Value Scale (RBRVS) is used to determine reimbursement amounts for practitioner services. The major problem that the CMS has encountered with funding prospective payment is DRG creep, in which health care providers up code or over bill a patient to indicate a need for financial reimbursement for more expensive health care services to recoup what the health care provider believes is a more equitable payment.

Health Care Should Be Health Care Should
1.

Скачать книгу